Medical haematology trial eligibility and the Duffy null‐associated neutrophil count: A cross‐sectional study
HemaSphere · 2025-10 · 9 (10)
DOI: 10.1002/hem3.70236 ↗Kurz gefasst
Leserbrief in der Zeitschrift HemaSphere, online erschienen am 06.10.2025. Verfasst von Olga Tsiamita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barts Health NHS Trust London UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Barts Health NHS Trust London UK.
- Blizard Institute Queen Mary University of London London UK.
- Department of Cardiovascular Sciences University of Birmingham Birmingham UK.
- NHS Blood and Transplant London UK.
- Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
- Department of Medicine, Mass General Brigham Division of Haematology/Oncology Boston Massachusetts USA.
ORCID-Profile: Stephen P Hibbs
Förderung
- Wellcome Trust
- NCI NIH HHS
Zitieren
APA
Tsiamita, O., Aiken, L., Badat, M., Lowe, G., Oyesanya, F., Wolf, S., Merz, L. E., Hantel, A., & Hibbs, S. P. (2025). Medical haematology trial eligibility and the Duffy null‐associated neutrophil count: A cross‐sectional study. HemaSphere, 9(10). https://doi.org/10.1002/hem3.70236
Vancouver
Tsiamita O, Aiken L, Badat M, Lowe G, Oyesanya F, Wolf S, et al. Medical haematology trial eligibility and the Duffy null‐associated neutrophil count: A cross‐sectional study. HemaSphere. 2025;9(10). doi:10.1002/hem3.70236
BibTeX
@article{Tsiamita2025,
author = {Tsiamita, Olga and Aiken, Laura and Badat, Mohsin and Lowe, Gill and Oyesanya, Funmi and Wolf, Sonia and Merz, Lauren E and Hantel, Andrew and Hibbs, Stephen P},
title = {Medical haematology trial eligibility and the Duffy null‐associated neutrophil count: A cross‐sectional study},
journal = {HemaSphere},
year = {2025},
volume = {9},
number = {10},
doi = {10.1002/hem3.70236}
}
EUVIMED